You are here: Industry Insights > financial results

News List

Teva Reports First Quarter 2017 Financial Results americanpharmaceuticalreview
May 15, 2017
Teva Pharmaceutical reported results for the quarter ended March 31, 2017.
Darling Ingredients Inc. Reports First Quarter 2017 Financial Results: en-cphi.cn
May 12, 2017
Darling Ingredients Inc. announced financial results for the 2017 first quarter ended April 1, 2017.
Endo Reports First-Quarter 2017 Financial Results americanpharmaceuticalreview
May 10, 2017
Endo International has reported first-quarter 2017 financial results.
Bristol-Myers Squibb Reports First Quarter Financial Results americanpharmaceuticalreview
April 28, 2017
Bristol-Myers Squibb posted first quarter 2017 revenues of $4.9 billion, an increase of 12% compared to the same period a year ago. Revenues increased 13% when adjusted for foreign exchange impact.
Astellas Reports FY2016 Financial Results americanpharmaceuticalreview
April 28, 2017
Astellas Pharma announced the financial results for fiscal year 2016 ended March 31, 2017. Sales for the full-year of FY2016 decreased by 4.4% compared to the previous fiscal year, resulting in 1,311.7 billion yen.
Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement lilly
April 12, 2017
Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2017 on Tuesday, April 25, 2017.
Actelion's fourth-quarter sales, profit rise, buoyed by Opsumit, Uptravi firstwordpharma
February 15, 2017
Actelion announced Tuesday that fourth-quarter sales reached 626.9 million Swiss francs ($622 million), up from 511.8 million francs ($507.7 million) in the year-ago period, boosted by revenue from the pulmonary arterial hypertension (PAH) treatments Opsu
Sun Pharma posts Rs 7,683 crs sales in Q3FY17 financialexpress
February 15, 2017
Registers a net profit of Rs 1,472 crores
QuintilesIMS Reports Fourth-Quarter and Full-Year 2016 Results, Issues First-Quarter and Full-Year 2 IMS Health
February 15, 2017
Revenue of $1,953 million, up 74.2 percent constant currency, 73.1 percent reported; on a combined company basis up 4.2 percent constant currency, 3.5 percent at actual FX rates when adjusting for $55 million of deferred revenue for the fourth quarter
QuintilesIMS to Announce Fourth-Quarter 2016 Results and Issue 2017 Guidance on February 14, 2017 IMS Health
February 08, 2017
Quintiles IMS Holdings, Inc. will announce its fourth-quarter and full-year 2016 financial results and issue 2017 guidance before the market opens on Tuesday, February 14, 2017.

Previous page 1 2 3 4 5 6 Next page